Welcure Drugs

{
  "main_header": {
    "sid": 736142,
    "name": "Welcure Drugs",
    "stock_name": "Welcure Drugs",
    "full_name": "Welcure Drugs & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/welcure-drugs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.30",
    "chg": 0.01,
    "chgp": "3.45%",
    "dir": 1,
    "prev_price": "0.29",
    "mcapval": "37.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524661,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE331C01025",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "67.66 lacs",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/welcure-drugs-736142-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/welcure-drugs-pharmaceuticals-ltd-is-rated-sell-3959074",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/WelcureDrugsPha_mojoScore_3959074.png",
        "date": "2026-04-23 10:10:04",
        "description": "Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 14 Nov 2025, reflecting a change in the company’s outlook at that time. However, all fundamentals, returns, and financial metrics discussed below are current as of 23 April 2026, providing an up-to-date view of the stock’s position in the market."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/welcure-drugs-pharmaceuticals-ltd-is-rated-sell-3939481",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/WelcureDrugsPha_mojoScore_3939481.png",
        "date": "2026-04-09 10:10:18",
        "description": "Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs 0.23 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-ltd-falls-to-52-week-low-of-023-3928657",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/WelcureDrugsPha_priceRelatedfactors_3928657.png",
        "date": "2026-04-01 10:02:51",
        "description": "A steep decline has pushed Welcure Drugs & Pharmaceuticals Ltd to a fresh 52-week low of Rs 0.23 on 1 Apr 2026, marking a significant 68.82% drop over the past year despite a broader market that has been relatively resilient."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.0.24",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-ltd-falls-to-52-week-low-of-rs024-3902542",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WelcureDrugsPha_priceRelatedfactors_3902542.png",
        "date": "2026-03-20 09:41:23",
        "description": "Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low price of Rs.0.24, marking a significant decline in its stock value amid a challenging market environment and company-specific factors."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.0.25",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-ltd-falls-to-52-week-low-of-rs025-3899975",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WelcureDrugsPha_priceRelatedfactors_3899975.png",
        "date": "2026-03-19 09:58:00",
        "description": "Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low price of Rs.0.25, marking a significant decline in its stock value amid broader market pressures and company-specific factors."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.0.26",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-ltd-falls-to-52-week-low-of-rs026-3894013",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WelcureDrugsPha_priceRelatedfactors_3894013.png",
        "date": "2026-03-16 12:44:42",
        "description": "Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low of Rs.0.26 today, marking a significant decline in its stock price amid a challenging market environment. This latest low reflects a year-long downward trend, with the stock underperforming its sector and benchmark indices."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low Amid Market Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/welcure-drugs-pharmaceuticals-ltd-falls-to-52-week-low-amid-market-downturn-3888549",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WelcureDrugsPha_priceRelatedfactors_3888549.png",
        "date": "2026-03-13 09:58:45",
        "description": "Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low of Rs.0.27, marking a significant decline in its stock price amid broader market weakness and sectoral pressures."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/welcure-drugs-pharmaceuticals-ltd-is-rated-sell-3873284",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WelcureDrugsPha_mojoScore_3873284.png",
        "date": "2026-03-05 10:10:02",
        "description": "Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Welcure Drugs & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/welcure-drugs-pharmaceuticals-ltd-is-rated-sell-3845619",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/WelcureDrugsPha_mojoScore_3845619.png",
        "date": "2026-02-18 10:10:25",
        "description": "Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      }
    ],
    "total": 291,
    "sid": "736142",
    "stock_news_url": "https://www.marketsmojo.com/news/welcure-drugs-pharmaceuticals-736142"
  },
  "announcements": [
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "23-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Welcure Drugs & Pharmaceuticals Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L68100DL1996PLC227773</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Palak Jain <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: welcuredrugs227@gmail.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Chintan Didawala Ganpat <br/> Designation: Managing Director and CFO <br/> EmailId: welcuredrugs227@gmail.com</div> </div> <div> <br/> Date: 23/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "03-Apr-2026",
      "details": "Certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulations 2018 for the 4th Quarter and Annual year ended 31st MArch 2026.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2026",
      "details": "Intimation of Closure of Trading Window for the 4th Quarter and Annual Year Ended 31 March 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Welcure Drugs & Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 16 Oct 25",
          "dt": "2025-10-16",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Welcure Drugs & Pharmaceuticals Ltd has announced <strong>1:10</strong> bonus issue, ex-date: 16 Oct 25",
          "dt": "2025-10-16",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Welcure Drugs & Pharmaceuticals Ltd is Rated Sell

2026-04-23 10:10:04

Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 14 Nov 2025, reflecting a change in the company’s outlook at that time. However, all fundamentals, returns, and financial metrics discussed below are current as of 23 April 2026, providing an up-to-date view of the stock’s position in the market.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd is Rated Sell

2026-04-09 10:10:18

Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs 0.23 Amidst Prolonged Downtrend

2026-04-01 10:02:51

A steep decline has pushed Welcure Drugs & Pharmaceuticals Ltd to a fresh 52-week low of Rs 0.23 on 1 Apr 2026, marking a significant 68.82% drop over the past year despite a broader market that has been relatively resilient.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.0.24

2026-03-20 09:41:23

Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low price of Rs.0.24, marking a significant decline in its stock value amid a challenging market environment and company-specific factors.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.0.25

2026-03-19 09:58:00

Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low price of Rs.0.25, marking a significant decline in its stock value amid broader market pressures and company-specific factors.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.0.26

2026-03-16 12:44:42

Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low of Rs.0.26 today, marking a significant decline in its stock price amid a challenging market environment. This latest low reflects a year-long downward trend, with the stock underperforming its sector and benchmark indices.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd Falls to 52-Week Low Amid Market Downturn

2026-03-13 09:58:45

Welcure Drugs & Pharmaceuticals Ltd has reached a new 52-week and all-time low of Rs.0.27, marking a significant decline in its stock price amid broader market weakness and sectoral pressures.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd is Rated Sell

2026-03-05 10:10:02

Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Welcure Drugs & Pharmaceuticals Ltd is Rated Sell

2026-02-18 10:10:25

Welcure Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

View All News